Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Overview
As previously disclosed in a Form 8-K filed by Sabra Health Care REIT, Inc.
("Sabra" or the "Company") on August 4, 2021, Harold Andrews, the Company's
Executive Vice President, Chief Financial Officer (Principal Financial Officer)
and Secretary, retired from Sabra effective December 31, 2021. Mr. Andrews will
remain in a consulting role with Sabra following his retirement pursuant to a
two-year consulting agreement, as described below.
Appointment of Chief Financial Officer
On December 30, 2021, Sabra's Board of Directors appointed Michael Costa,
Sabra's Executive Vice President - Finance and Chief Accounting Officer
(Principal Accounting Officer), to succeed Mr. Andrews as the Company's
Executive Vice President, Chief Financial Officer (Principal Financial Officer)
and Secretary, in each case effective January 1, 2022. In this position,
Mr. Costa will also continue to serve as the Company's principal accounting
officer. Mr. Costa, 43, has served as Sabra's Executive Vice President - Finance
since August 2017 and as Sabra's Chief Accounting Officer (Principal Accounting
Officer) since January 2021. From June 2016 through August 2017, Mr. Costa
served as Sabra's Vice President - Finance and Controller. From Sabra's
inception in 2010 until June 2016, Mr. Costa served as Sabra's Controller.
On December 28, 2021, the Compensation Committee of Sabra's Board of Directors
approved an employment agreement between the Company and Mr. Costa (the
"Employment Agreement"), which agreement is effective as of January 1, 2022. The
Employment Agreement provides for an initial annual base salary of $450,000 that
is subject to annual merit increases and an annual incentive bonus pursuant to
the Company's Executive Bonus Plan. The Employment Agreement also provides that
Mr. Costa is entitled to participate in the Company's benefit programs for its
senior executives, to accrue paid time off in accordance with the Company's
policy for senior executive officers and to be reimbursed for his business
expenses.
In the event that Mr. Costa's employment is terminated by the Company without
"good cause" or by Mr. Costa for "good reason" (as those terms are defined in
the Employment Agreement), he will be entitled to a lump sum cash severance
payment equal to the sum of his annual base salary then in effect and the
average of the annual bonus he actually earned for the preceding three years,
multiplied by a severance multiplier equal to 1.5, plus any accrued and unpaid
bonus for any prior fiscal year and a prorated bonus payment for the year in
which the termination occurs. Mr. Costa and his family members will also be
entitled to continued coverage under the Company's health plans or, at
Mr. Costa's option, a monthly cash payment equal to the applicable COBRA premium
for such continued coverage, for a period of up to 18 months, except that if
such termination occurs on or within two years following a change in control of
the Company, the period will be up to 24 months following the date of
termination. In the event Mr. Costa's employment is terminated by the Company
without good cause or by Mr. Costa for good reason on or within two years
following a change in control of the Company, he will be entitled to a lump sum
cash severance payment equal to the sum of his annual base salary then in effect
and the average of the annual bonus he actually earned for the preceding three
years, multiplied by a severance multiplier of two, plus any accrued and unpaid
bonus for any prior fiscal year and a prorated target bonus payment for the year
in which the termination occurs (which would be calculated assuming the Company
achieves 100% of the financial performance target(s) applicable to the bonus for
such fiscal year). Mr. Costa's right to receive severance payments pursuant to
the Employment Agreement is conditioned upon his execution and delivery of (and
not revoking) a general release in favor of the Company. In addition, if any
payments under the Employment Agreement trigger the excise tax imposed by
Section 4999 of the Internal Revenue Code, payments to Mr. Costa will be reduced
as provided in the agreement to a level that does not trigger the excise tax if
the total after-tax benefit of such reduction exceeds the total after-tax
benefit if such reduction is not made.
Pursuant to the Employment Agreement, Mr. Costa agrees that he will not disclose
any confidential information of the Company at any time during or after
employment with the Company. In addition, Mr. Costa has agreed that, for a
period of one year following a termination of employment with the Company, he
will not solicit the Company's employees or customers or interfere with any of
the Company's business relationships.
--------------------------------------------------------------------------------
The term of the Employment Agreement is for an initial period of three years and
annually renews for a one-year period on each anniversary of the January 1, 2022
effective date; provided, however, that if after the first year of the term,
either party to the agreement provides 60 days' notice prior to the anniversary
of the effective date of the agreement, the agreement will terminate on the
anniversary of the effective date occurring in the second year following the
year in which such notice was provided.
In connection with his appointment, Mr. Costa will also enter into an
indemnification agreement with the Company, the form of which is described below
and filed as Exhibit 10.3 to this Current Report on Form 8-K.
There is no arrangement or understanding between Mr. Costa and any other person
pursuant to which he was selected as an officer. Mr. Costa has no family
relationship with any director, executive officer, or person nominated or chosen
by the Company to become a director or executive officer, and he has no direct
or indirect material interest in any transaction required to be disclosed
pursuant to Item 404(a) of Regulation S-K.
Consulting Agreement with Former Chief Financial Officer
On December 30, 2021, the Company entered into a consulting agreement with
Mr. Andrews (the "Consulting Agreement"), effective as of December 31, 2021,
pursuant to which Mr. Andrews will provide consulting services to the Company as
an independent contractor for two years following his retirement. The consulting
services will consist of such services as are reasonably requested by Sabra
through the Company's Board of Directors or Chief Executive Officer in
connection with transitioning Mr. Costa into the position of Chief Financial
Officer.
The Consulting Agreement provides for an annual consulting fee of $500,000,
reimbursements for expenses incurred in performing services under the Consulting
Agreement, and certain reimbursements for the cost of COBRA premiums. In
addition, the unvested portion of the time-based and performance-based equity
awards granted to Mr. Andrews during his previous employment with the Company
will continue to vest during the term of the Consulting Agreement. The services
provided pursuant to the Consulting Agreement are non-exclusive, and Mr. Andrews
will not be entitled to any fringe benefits under the Consulting Agreement.
As a condition to entering into the Consulting Agreement, Mr. Andrews must
provide the Company with (and not revoke) a valid, executed general release
agreement in favor of the Company. In addition, Mr. Andrews has agreed that he
will not disclose any confidential information of the Company at any time during
or after the term of the Consulting Agreement. The Consulting Agreement will
terminate in accordance with its terms on December 31, 2023.
New Form of Indemnification Agreement
On December 30, 2021, Sabra's Board of Directors approved an updated form of
director and officer indemnification agreement (the "Indemnification Agreement")
to be entered into between Sabra and each person holding office as a director or
officer of Sabra on or after such date. The Indemnification Agreement provides
that Sabra will, in certain circumstances, indemnify each of the covered
directors and officers to the maximum extent permitted by Maryland law for
claims arising in such person's capacity as a director or officer of Sabra. The
rights of each director or officer party to an Indemnification Agreement are in
addition to any other rights such person may have under Sabra's charter, bylaws,
or otherwise under Maryland law. The Indemnification Agreement will replace the
Company's existing indemnification agreements in place with the Company's
directors and executive officers.
The foregoing summary of each of the Employment Agreement, Consulting Agreement
and Indemnification Agreement is qualified in its entirety by reference to the
full text of these agreements, which are attached hereto as Exhibits 10.1, 10.2
and 10.3, respectively, and are incorporated in this Item 5.02 by reference.
--------------------------------------------------------------------------------
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No. Description
10.1 Employment Agreement, dated January 1, 2022, by and between Michael
Costa and Sabra Health Care REIT, Inc.
10.2 Consulting Agreement, dated December 30, 2021, by and between Harold
W. Andrews, Jr. and Sabra Health Care REIT, Inc.
10.3 Form of Indemnification Agreement to be entered into with each of
the directors and officers of Sabra.
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses